BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2016
View Archived Issues
Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection
Read More
New phase Ib study investigates dantrolene sodium for Wolfram syndrome
Read More
Primex Pharmaceuticals submits MAA for ADV-6209
Read More
Synthetic Biologics awarded CDC contract for SYN-004
Read More
RedHill Biopharma provides update on phase III study of RHB-104
Read More
Asceneuron receives grant from MJFF
Read More
ICU Medical to acquire Pfizer's Hospira Infusion Systems business
Read More
Vaccinex, Merck KGaA form collaboration to evaluate VX15/2503 plus avelumab in NSCLC
Read More
Santen, RIKEN and FBRI to develop novel retinal disease treatments
Read More
Engility awarded task order by Walter Reed for Chikungunya virus vaccine work
Read More
FDA accepts Coherus' BLA submission for pegfilgrastim biosimilar
Read More
ZF-AAV constructs enables long-term mutant Huntingtin repression in mice
Read More
Promising phase II data presented for E-52862
Read More
First patient enrolled in Reata Pharmaceuticals' phase III study of bardoxolone methyl
Read More
Boston Therapeutics and Advance Pharmaceutical report topline data from study of BTI-320
Read More
University of Ljubljana patents PSMB8 inhibitors
Read More
NIH grant supports work at IDRI to develop RNA-based Zika virus vaccine
Read More
Akarna Therapeutics discloses FXR agonists
Read More
Shanghai Yingli Pharmaceutical describes URAT1 inhibitors
Read More
Mironid develops PDE4 activators
Read More
Hokkaido University presents oxidative stress-induced cell death inhibitors
Read More
AstraZeneca to divest ex-U.S. Rhinocort Aqua rights to Cilag
Read More
MonoSol Rx and Lupin to develop pediatric products utilizing PharmFilm technology
Read More
EMA grants orphan drug designation to Videregen's replacement trachea product
Read More
TRPM8 antagonist attenuates oxaliplatin-induced cold allodynia in vivo
Read More
GSK makes success payment to Cancer Research Technology and University of Manchester
Read More
Teva to commercialize two Celltrion biosimilar candidates in U.S. and Canada
Read More
NIH awards support research on the peripheral nervous system
Read More